Literature DB >> 30971536

Topical steroids: Awareness and misuse among patients, pharmacists and general medical practitioner.

Niral K Sheth1, Pragya Ashok Nair1.   

Abstract

AIMS AND
OBJECTIVES: (1) To determine the level of awareness among patients, pharmacists and general practitioners about commonly available topical steroids and its combinations.(2) To determine the source of recommendation/prescription of topical steroids and its combination creams.(3) To know and create awareness about the side effects of topical steroids in all the study groups.
METHODS: This was a prospective questionnaire-based study where three study groups, namely patients, pharmacists and general practitioners, were included. This study was approved by the institutional ethics committee. after ethical clearance. The patients who used topical steroids for dermatoses where it is an absolute contraindication, as well as those who developed side effects, were included in the study. ThoroughComplete cutaneous examination was done specifically to detect the side effects of steroids. Seminars were conducted and questionnaires were given to both the pharmacists and general practitioners of nearby areas. The questionnaire consisted of questions regarding their prescription and dispensing practices of topical steroids and its combinations.
RESULTS: Out of 95 patients seen, the most commonly used steroid molecule was clobetasol propionate 0.05% in 44 (46.3%) patients, the common source of recommendation was general practitioners in 36 (37.8%), the common indication was superficial dermatophytosis in 85 (89%) and the most common adverse effect was recurrence/increase in the extent of the infection in 72 (75.78%) patients. Out of total 44 general practitioners enrolled in the study, 22 (50%) were qualified allopathic medical practitioners and22 (50%) were homeopathic/ayurvedic doctors. Superficial dermatophytosis [19 (43.18%)] was the common dermatosis seen by them. While 29 (65.90%) preferred prescribing topical steroids or its combination, rest of them preferred plain steroid creams. Out of 179 pharmacists, 74 (41.34%) did not have appropriate knowledge of topical steroids, 35 (19.55%) were not aware that steroids are isschedule "H" drugs. Commonest molecule sold over the counterwas clobetasol propionate 0.05% by 74 (41.89%). The limitations of our study were small study group and short duration.
CONCLUSION: As dermatologists, it is our responsibility, to correctly educate the society, particularly the non-dermatologist medical fraternity, about ethical and rational use of topical steroids.

Entities:  

Keywords:  Clobetasol propionate; dermatophytosis; topical steroids

Year:  2021        PMID: 30971536     DOI: 10.4103/ijdvl.IJDVL_84_18

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  6 in total

1.  Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients.

Authors:  Abir Saraswat; Koushik Lahiri; Manas Chatterjee; Shyamanta Barua; Arijit Coondoo; Asit Mittal; Saumya Panda; Murlidhar Rajagopalan; Rajeev Sharma; Anil Abraham; Shyam B Verma; C R Srinivas
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Mar-Apr       Impact factor: 2.545

2.  Misuse of topical corticosteroids: A clinical study of adverse effects.

Authors:  Vivek Kumar Dey
Journal:  Indian Dermatol Online J       Date:  2014-10

3.  Misuse of topical corticosteroids on the face: A cross-sectional study among dermatology outpatients.

Authors:  Abhijeet Kumar Jha; Rajesh Sinha; Smita Prasad
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

4.  Topical Steroid Awareness and Abuse: A Prospective Study among Dermatology Outpatients.

Authors:  T S Nagesh; A Akhilesh
Journal:  Indian J Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.494

5.  Prescribing practices of topical corticosteroids in the outpatient dermatology department of a rural tertiary care teaching hospital.

Authors:  Suvarna S Rathod; Vijay M Motghare; Vinod S Deshmukh; Rushikesh P Deshpande; Chetanraj G Bhamare; Jyoti R Patil
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

6.  Abuse of topical corticosteroids in India: Concerns and the way forward.

Authors:  Subodh Kumar; Aman Goyal; Yogendra Kumar Gupta
Journal:  J Pharmacol Pharmacother       Date:  2016 Jan-Mar
  6 in total
  1 in total

Review 1.  Trichophyton indotineae-An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India and Worldwide-A Multidimensional Perspective.

Authors:  Silke Uhrlaß; Shyam B Verma; Yvonne Gräser; Ali Rezaei-Matehkolaei; Maryam Hatami; Martin Schaller; Pietro Nenoff
Journal:  J Fungi (Basel)       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.